GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Other Current Receivables

Stella Diagnostics (Stella Diagnostics) Other Current Receivables : $0.00 Mil (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Other Current Receivables?

Stella Diagnostics's Other Current Receivables for the quarter that ended in Sep. 2023 was $0.00 Mil.


Stella Diagnostics Other Current Receivables Historical Data

The historical data trend for Stella Diagnostics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Other Current Receivables Chart

Stella Diagnostics Annual Data
Trend
Other Current Receivables

Stella Diagnostics Quarterly Data
Sep22 Sep23
Other Current Receivables - -

Stella Diagnostics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Stella Diagnostics Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Diagnostics (Stella Diagnostics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104
Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.

Stella Diagnostics (Stella Diagnostics) Headlines

From GuruFocus